- Home
- SGMT vs WALD Comparison
SGMT vs WALD Comparison
Compare SGMT & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMT
- WALD
- Stock Information
- Founded
- SGMT 2006
- WALD 1988
- Country
- SGMT United States
- WALD United States
- Employees
- SGMT N/A
- WALD N/A
- Industry
- SGMT
- WALD Package Goods/Cosmetics
- Sector
- SGMT
- WALD Consumer Discretionary
- Exchange
- SGMT Nasdaq
- WALD Nasdaq
- Market Cap
- SGMT 269.2M
- WALD 306.3M
- IPO Year
- SGMT 2023
- WALD 2021
- Fundamental
- Price
- SGMT $8.71
- WALD $1.84
- Analyst Decision
- SGMT Strong Buy
- WALD Strong Buy
- Analyst Count
- SGMT 8
- WALD 5
- Target Price
- SGMT $27.25
- WALD $5.16
- AVG Volume (30 Days)
- SGMT 722.5K
- WALD 128.9K
- Earning Date
- SGMT 08-13-2025
- WALD 08-18-2025
- Dividend Yield
- SGMT N/A
- WALD N/A
- EPS Growth
- SGMT N/A
- WALD N/A
- EPS
- SGMT N/A
- WALD N/A
- Revenue
- SGMT N/A
- WALD $273,868,000.00
- Revenue This Year
- SGMT N/A
- WALD $14.78
- Revenue Next Year
- SGMT N/A
- WALD $15.84
- P/E Ratio
- SGMT N/A
- WALD N/A
- Revenue Growth
- SGMT N/A
- WALD 25.55
- 52 Week Low
- SGMT $1.73
- WALD $1.60
- 52 Week High
- SGMT $11.41
- WALD $4.74
- Technical
- Relative Strength Index (RSI)
- SGMT 55.77
- WALD 41.49
- Support Level
- SGMT $8.62
- WALD $1.61
- Resistance Level
- SGMT $10.06
- WALD $1.95
- Average True Range (ATR)
- SGMT 0.70
- WALD 0.16
- MACD
- SGMT -0.05
- WALD 0.01
- Stochastic Oscillator
- SGMT 58.06
- WALD 33.80
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.